PDCO
77
3
KIM
58
2
NEM
30
2
HCP
54
2
APH
53
3
THC
52
9
RF
44
10
PNR
56
2
NSC
33
6
XEL
48
11
CF
47
5
ZTS
38
4
LNC
28
3
NWSA
69
4
CME
59
3
SJM
17
5
AMAT
33
3
ESS
44
5
AFL
34
6
MCO
67
3
PDCO
77
3
KIM
58
2
NEM
30
2
HCP
54
2
APH
53
3
THC
52
9
RF
44
10
PNR
56
2
NSC
33
6
XEL
48
11
CF
47
5
ZTS
38
4
LNC
28
3
NWSA
69
4
CME
59
3
SJM
17
5
AMAT
33
3
ESS
44
5
AFL
34
6
MCO
67
3
Financhill
Back

Amicus Therapeutics 10K Form

Sell
44

FOLD
Amicus Therapeutics

Last Price:
$9.78
Seasonality Move:
5.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09 10Q FOLD/Amicus Therapeutics Quarterly
2023-11-08 10Q FOLD/Amicus Therapeutics Quarterly
2023-08-08 10Q FOLD/Amicus Therapeutics Quarterly
2023-05-10 10Q FOLD/Amicus Therapeutics Quarterly
2022-11-07 10Q FOLD/Amicus Therapeutics Quarterly
2022-08-04 10Q FOLD/Amicus Therapeutics Quarterly

Receive FOLD News And Ratings

See the #1 stock for the next 7 days that we like better than FOLD

FOLD Financial Statistics

Sales & Book Value

Annual Sales: $399.4M
Cash Flow: $-23.3M
Price / Cash Flow: 0
Annual Sales: $0.60
Price / Book: 16.38

Profitability

EPS (TTM): -0.34000
Net Income (TTM): $-104.7M
Gross Margin: $362M
Return on Equity: -71.17%
Return on Assets: -13.78%

Amicus Therapeutics Earnings Forecast

Key Amicus Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 21 years for FOLD is 90.65%.
  • The Selling, General & Administrative Expenses for FOLD have been equal to 68.93% of Gross Profit Margin.
  • The Research & Development expenses have been 38.16% of Revenue.
  • The Interest Expense is -33.08% of Operating Income.
  • The Net Earning history of FOLD is -37.96% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 11 years.

Amicus Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: FOLD
CUSIP: 03152W
Website: amicusrx.com

Debt

Debt-to-Equity Ratio: 2.18
Current Ratio: 3.15
Quick Ratio: 2.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 26.88

FOLD Technical Analysis vs Fundamental Analysis

Sell
44
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy or a Sell?